Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast 0.15% Cream for Pruritus in Atopic Dermatitis
NCT07560618Phase 4Recruiting
- Sponsor
- Integrative Skin Science and Research
- Start
- Jul 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 4 trial of roflumilast vehicle cream in atopic dermatitis (AD), sponsored by Integrative Skin Science and Research. Started Jul 2026; status: recruiting.
02
Drugs
roflumilast vehicle cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07560618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07560618.